Nanoviricides Inc (NNVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,305 | -7,747 | -4,608 | -3,061 | -10,725 |
| Depreciation Amortization | 2,011 | 1,620 | 1,157 | 569 | 2,087 |
| Accounts payable and accrued liabilities | -388 | -751 | -705 | 64 | 458 |
| Other Working Capital | -486 | -1,190 | -670 | 43 | 337 |
| Other Operating Activity | 1,270 | 1,179 | -10 | 161 | 1,014 |
| Operating Cash Flow | $-7,898 | $-6,889 | $-4,836 | $-2,225 | $-6,829 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -165 | -119 | -24 | -24 | -476 |
| Investing Cash Flow | $-165 | $-119 | $-24 | $-24 | $-476 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,000 | -1,000 | N/A | N/A | N/A |
| Financing Cash Flow | $-1,000 | $-1,000 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 24,162 | 24,162 | 24,162 | 24,162 | 31,468 |
| End Cash Position | 15,100 | 16,155 | 19,302 | 21,913 | 24,162 |
| Net Cash Flow | $-9,063 | $-8,007 | $-4,861 | $-2,249 | $-7,306 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,898 | -6,889 | -4,836 | -2,225 | -6,829 |
| Capital Expenditure | -165 | -119 | -24 | -24 | -476 |
| Free Cash Flow | -8,063 | -7,007 | -4,861 | -2,249 | -7,306 |